Research Article
Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis
Table 5
Fibrosis risk score testing at the 6th and 12th month.
| | 13–15 mg/kg/d | 18–22 mg/kg/d | value |
| 6 month | | | | APRI | 1.016 (0.530, 2.012) | 0.615 (0.473, 1.135) | 0.041 | FIB-4 | 2.501 (1.550, 4.814) | 1.729 (1.193, 2.549) | 0.018 | 12 month | | | | APRI | 1.165 (0.641, 2.038) | 0.731 (0.467, 1.114) | 0.008 | FIB-4 | 2.874 (1.794, 4.993) | 2.036 (1.343, 2.691) | 0.013 |
|
|
Note. APRI, aspartate aminotransferase/platelet ratio index; FIB-4, fibrosis index based on the four factors.
|